IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,256,879 | -10.2% | 130,517 | -0.8% | 0.00% | – |
Q2 2023 | $1,400,085 | -65.3% | 131,587 | -65.7% | 0.00% | -100.0% |
Q1 2023 | $4,040,321 | +221.4% | 384,061 | +278.5% | 0.00% | – |
Q4 2022 | $1,257,263 | +554.8% | 101,474 | +447.9% | 0.00% | – |
Q3 2022 | $192,000 | -98.2% | 18,519 | -97.8% | 0.00% | -100.0% |
Q1 2022 | $10,829,000 | +116.8% | 860,848 | +100.9% | 0.00% | +100.0% |
Q4 2021 | $4,996,000 | +105.5% | 428,527 | +130.2% | 0.00% | – |
Q3 2021 | $2,431,000 | -41.1% | 186,134 | -42.0% | 0.00% | – |
Q2 2021 | $4,129,000 | -15.1% | 320,835 | -26.3% | 0.00% | -100.0% |
Q1 2021 | $4,865,000 | +11.2% | 435,074 | +13.3% | 0.00% | 0.0% |
Q4 2020 | $4,375,000 | -25.3% | 384,143 | -41.0% | 0.00% | -50.0% |
Q3 2020 | $5,858,000 | -24.0% | 651,246 | -12.8% | 0.00% | -33.3% |
Q2 2020 | $7,710,000 | +0.4% | 747,047 | -1.9% | 0.00% | 0.0% |
Q1 2020 | $7,682,000 | -57.0% | 761,327 | -43.3% | 0.00% | -62.5% |
Q4 2019 | $17,867,000 | -19.3% | 1,342,365 | -47.9% | 0.01% | -20.0% |
Q3 2019 | $22,134,000 | -51.3% | 2,578,169 | -37.9% | 0.01% | -52.4% |
Q2 2019 | $45,418,000 | +0.1% | 4,151,562 | +23.8% | 0.02% | -4.5% |
Q1 2019 | $45,358,000 | +183.5% | 3,352,438 | +117.1% | 0.02% | +175.0% |
Q4 2018 | $15,998,000 | +74.4% | 1,544,085 | +210.8% | 0.01% | +100.0% |
Q3 2018 | $9,172,000 | -14.2% | 496,833 | -11.1% | 0.00% | -20.0% |
Q2 2018 | $10,687,000 | +165.2% | 558,918 | +114.0% | 0.01% | +150.0% |
Q1 2018 | $4,030,000 | +2568.9% | 261,195 | +2486.1% | 0.00% | – |
Q4 2017 | $151,000 | -38.9% | 10,100 | -22.9% | 0.00% | – |
Q2 2017 | $247,000 | -93.1% | 13,100 | -94.2% | 0.00% | -100.0% |
Q3 2016 | $3,557,000 | +2574.4% | 223,997 | +2097.3% | 0.00% | – |
Q2 2016 | $133,000 | -96.1% | 10,194 | -96.9% | 0.00% | -100.0% |
Q3 2015 | $3,391,000 | -29.3% | 325,483 | +8.6% | 0.00% | -40.0% |
Q1 2015 | $4,793,000 | +492.5% | 299,582 | +467.5% | 0.01% | +400.0% |
Q4 2014 | $809,000 | -72.0% | 52,792 | -76.3% | 0.00% | -66.7% |
Q3 2014 | $2,887,000 | +527.6% | 222,892 | +642.7% | 0.00% | +200.0% |
Q2 2014 | $460,000 | -42.7% | 30,010 | -53.9% | 0.00% | 0.0% |
Q1 2014 | $803,000 | -81.2% | 65,135 | -82.3% | 0.00% | -83.3% |
Q4 2013 | $4,276,000 | +191.3% | 368,278 | +197.3% | 0.01% | +200.0% |
Q3 2013 | $1,468,000 | +17.7% | 123,878 | -1.1% | 0.00% | 0.0% |
Q2 2013 | $1,247,000 | – | 125,316 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |